| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enterococcus faecium | 20 | 2024 | 33 | 4.280 |
Why?
|
| Anti-Bacterial Agents | 13 | 2024 | 836 | 2.170 |
Why?
|
| Gram-Positive Bacterial Infections | 8 | 2024 | 52 | 1.850 |
Why?
|
| Bacterial Proteins | 21 | 2024 | 878 | 1.840 |
Why?
|
| Fimbriae, Bacterial | 9 | 2016 | 24 | 1.550 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 7 | 2024 | 52 | 1.250 |
Why?
|
| Cross Infection | 8 | 2024 | 155 | 1.240 |
Why?
|
| Fimbriae Proteins | 6 | 2012 | 15 | 1.160 |
Why?
|
| beta-Lactamases | 6 | 2024 | 57 | 1.060 |
Why?
|
| Cephalosporins | 2 | 2018 | 25 | 1.010 |
Why?
|
| Biofilms | 9 | 2017 | 50 | 0.990 |
Why?
|
| Microbial Sensitivity Tests | 8 | 2024 | 146 | 0.980 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2023 | 41 | 0.870 |
Why?
|
| Enterococcus | 2 | 2017 | 34 | 0.800 |
Why?
|
| Bacteroides | 1 | 2023 | 35 | 0.800 |
Why?
|
| Teichoic Acids | 4 | 2017 | 18 | 0.790 |
Why?
|
| Intestinal Mucosa | 3 | 2018 | 824 | 0.730 |
Why?
|
| Lipopolysaccharides | 4 | 2017 | 300 | 0.710 |
Why?
|
| Cell Wall | 6 | 2017 | 71 | 0.690 |
Why?
|
| Klebsiella Infections | 3 | 2024 | 32 | 0.610 |
Why?
|
| Klebsiella pneumoniae | 3 | 2024 | 35 | 0.610 |
Why?
|
| Immunity, Mucosal | 1 | 2018 | 71 | 0.530 |
Why?
|
| Biosynthetic Pathways | 1 | 2017 | 16 | 0.500 |
Why?
|
| Drug Synergism | 1 | 2017 | 315 | 0.480 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 87 | 0.480 |
Why?
|
| Bacillus cereus | 2 | 2012 | 9 | 0.470 |
Why?
|
| Gram-Positive Bacteria | 2 | 2013 | 19 | 0.430 |
Why?
|
| Dysbiosis | 1 | 2015 | 91 | 0.430 |
Why?
|
| Colon | 1 | 2018 | 540 | 0.430 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2013 | 82 | 0.400 |
Why?
|
| Adhesins, Bacterial | 2 | 2013 | 36 | 0.400 |
Why?
|
| Staphylococcus aureus | 5 | 2016 | 284 | 0.390 |
Why?
|
| Membrane Proteins | 7 | 2015 | 1260 | 0.380 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2024 | 199 | 0.380 |
Why?
|
| Gene Expression Regulation, Bacterial | 7 | 2015 | 204 | 0.370 |
Why?
|
| Staphylococcal Infections | 4 | 2023 | 286 | 0.350 |
Why?
|
| Aminoacyltransferases | 1 | 2011 | 10 | 0.340 |
Why?
|
| Cysteine Endopeptidases | 1 | 2011 | 87 | 0.330 |
Why?
|
| Enterococcus faecalis | 3 | 2017 | 57 | 0.310 |
Why?
|
| Community-Acquired Infections | 1 | 2010 | 65 | 0.310 |
Why?
|
| Bacterial Adhesion | 7 | 2016 | 83 | 0.300 |
Why?
|
| Virulence Factors | 5 | 2023 | 113 | 0.290 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2014 | 56 | 0.280 |
Why?
|
| Oxidoreductases | 1 | 2008 | 111 | 0.280 |
Why?
|
| Organoids | 2 | 2019 | 76 | 0.270 |
Why?
|
| Netherlands | 5 | 2024 | 25 | 0.270 |
Why?
|
| Nisin | 2 | 2017 | 4 | 0.240 |
Why?
|
| Mucus | 3 | 2016 | 19 | 0.220 |
Why?
|
| Microscopy, Electron, Transmission | 5 | 2015 | 137 | 0.220 |
Why?
|
| Humans | 31 | 2024 | 93615 | 0.220 |
Why?
|
| Molecular Sequence Data | 7 | 2015 | 2889 | 0.220 |
Why?
|
| Multigene Family | 5 | 2023 | 202 | 0.220 |
Why?
|
| Vancomycin-Resistant Enterococci | 1 | 2024 | 14 | 0.220 |
Why?
|
| Azabicyclo Compounds | 1 | 2024 | 4 | 0.210 |
Why?
|
| Ceftazidime | 1 | 2024 | 8 | 0.210 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 3 | 2013 | 11 | 0.210 |
Why?
|
| Animals | 15 | 2019 | 28041 | 0.210 |
Why?
|
| Agglutination | 2 | 2015 | 16 | 0.210 |
Why?
|
| Drug Combinations | 1 | 2024 | 200 | 0.210 |
Why?
|
| Phylogeny | 4 | 2024 | 1265 | 0.200 |
Why?
|
| Pseudomonas Infections | 1 | 2024 | 94 | 0.200 |
Why?
|
| Whole Genome Sequencing | 1 | 2024 | 109 | 0.200 |
Why?
|
| Genome, Bacterial | 3 | 2010 | 142 | 0.200 |
Why?
|
| Infection Control | 1 | 2024 | 131 | 0.190 |
Why?
|
| Probiotics | 2 | 2016 | 92 | 0.190 |
Why?
|
| Calcium | 2 | 2019 | 1175 | 0.190 |
Why?
|
| DNA, Bacterial | 4 | 2013 | 232 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2019 | 590 | 0.180 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 85 | 0.180 |
Why?
|
| Temperature | 4 | 2015 | 423 | 0.170 |
Why?
|
| Membrane Glycoproteins | 3 | 2016 | 443 | 0.170 |
Why?
|
| Mice | 9 | 2019 | 12233 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 885 | 0.170 |
Why?
|
| Genomic Islands | 2 | 2011 | 14 | 0.160 |
Why?
|
| Sepsis | 3 | 2015 | 388 | 0.160 |
Why?
|
| Genes, Bacterial | 3 | 2012 | 150 | 0.150 |
Why?
|
| Animal Feed | 1 | 2019 | 22 | 0.150 |
Why?
|
| Feces | 3 | 2019 | 360 | 0.150 |
Why?
|
| Peritoneum | 1 | 2019 | 52 | 0.150 |
Why?
|
| Peritoneal Dialysis | 1 | 2019 | 31 | 0.150 |
Why?
|
| Fibrinogen | 2 | 2016 | 49 | 0.150 |
Why?
|
| Peptidoglycan | 3 | 2015 | 30 | 0.150 |
Why?
|
| Abdominal Wall | 1 | 2019 | 32 | 0.150 |
Why?
|
| Gastrectomy | 1 | 2019 | 71 | 0.150 |
Why?
|
| Mouth Mucosa | 1 | 2019 | 71 | 0.140 |
Why?
|
| Dietary Supplements | 1 | 2019 | 131 | 0.140 |
Why?
|
| Cryptosporidium | 1 | 2018 | 4 | 0.140 |
Why?
|
| Cryptosporidiosis | 1 | 2018 | 6 | 0.140 |
Why?
|
| Gastric Bypass | 1 | 2019 | 114 | 0.140 |
Why?
|
| Penis | 1 | 2018 | 61 | 0.130 |
Why?
|
| Urethra | 1 | 2018 | 113 | 0.130 |
Why?
|
| Depsipeptides | 1 | 2017 | 29 | 0.130 |
Why?
|
| Microbial Interactions | 1 | 2016 | 12 | 0.120 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 179 | 0.120 |
Why?
|
| Staphylococcal Vaccines | 1 | 2016 | 17 | 0.120 |
Why?
|
| Blotting, Western | 4 | 2013 | 775 | 0.120 |
Why?
|
| Vancomycin | 1 | 2017 | 75 | 0.120 |
Why?
|
| Osteomyelitis | 1 | 2016 | 56 | 0.120 |
Why?
|
| Antibodies, Bacterial | 1 | 2016 | 103 | 0.120 |
Why?
|
| Mucin-2 | 1 | 2015 | 12 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2017 | 113 | 0.120 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2015 | 18 | 0.120 |
Why?
|
| Models, Animal | 1 | 2017 | 281 | 0.120 |
Why?
|
| Uridine Diphosphate N-Acetylmuramic Acid | 1 | 2015 | 1 | 0.120 |
Why?
|
| Microscopy, Atomic Force | 2 | 2013 | 53 | 0.110 |
Why?
|
| Lipopeptides | 1 | 2015 | 20 | 0.110 |
Why?
|
| Fibronectins | 1 | 2015 | 100 | 0.110 |
Why?
|
| Prophages | 1 | 2015 | 3 | 0.110 |
Why?
|
| Virus Release | 1 | 2015 | 6 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2015 | 150 | 0.110 |
Why?
|
| Ukraine | 2 | 2024 | 22 | 0.110 |
Why?
|
| Quorum Sensing | 1 | 2015 | 28 | 0.110 |
Why?
|
| Multilocus Sequence Typing | 2 | 2024 | 13 | 0.110 |
Why?
|
| Virulence | 3 | 2011 | 273 | 0.110 |
Why?
|
| Endocarditis, Bacterial | 1 | 2015 | 37 | 0.110 |
Why?
|
| Precision Medicine | 1 | 2019 | 456 | 0.110 |
Why?
|
| Cadherins | 1 | 2015 | 180 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2018 | 463 | 0.100 |
Why?
|
| Protein Multimerization | 2 | 2012 | 191 | 0.100 |
Why?
|
| Ctenocephalides | 1 | 2014 | 1 | 0.100 |
Why?
|
| Yersinia pestis | 1 | 2014 | 24 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2017 | 661 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2008 | 2020 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 726 | 0.100 |
Why?
|
| Hospitals | 2 | 2024 | 330 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2013 | 238 | 0.100 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2013 | 34 | 0.100 |
Why?
|
| Bacillaceae Infections | 1 | 2012 | 1 | 0.100 |
Why?
|
| Intestines | 1 | 2015 | 432 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 69 | 0.090 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2012 | 12 | 0.090 |
Why?
|
| Obesity | 1 | 2019 | 1019 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1516 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 1073 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 86 | 0.090 |
Why?
|
| Collagen | 2 | 2013 | 300 | 0.090 |
Why?
|
| Bacillus anthracis | 1 | 2012 | 73 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2012 | 120 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 169 | 0.090 |
Why?
|
| Mammals | 1 | 2013 | 259 | 0.080 |
Why?
|
| Protein Sorting Signals | 1 | 2011 | 40 | 0.080 |
Why?
|
| Bacterial Vaccines | 1 | 2011 | 44 | 0.080 |
Why?
|
| Elapid Venoms | 1 | 2010 | 5 | 0.080 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2010 | 12 | 0.080 |
Why?
|
| Microbiota | 1 | 2015 | 425 | 0.080 |
Why?
|
| Molecular Weight | 1 | 2010 | 279 | 0.080 |
Why?
|
| RNA, Bacterial | 2 | 2007 | 101 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 639 | 0.080 |
Why?
|
| Blotting, Southern | 1 | 2009 | 107 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2011 | 179 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 1993 | 0.070 |
Why?
|
| Gene Expression | 2 | 2013 | 1302 | 0.070 |
Why?
|
| Ampicillin Resistance | 1 | 2009 | 3 | 0.070 |
Why?
|
| Bacterial Typing Techniques | 1 | 2009 | 28 | 0.070 |
Why?
|
| Dog Diseases | 1 | 2009 | 36 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 2544 | 0.070 |
Why?
|
| Carrier State | 1 | 2009 | 40 | 0.070 |
Why?
|
| Disease Reservoirs | 1 | 2009 | 23 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 367 | 0.070 |
Why?
|
| Crystallography, X-Ray | 3 | 2016 | 520 | 0.070 |
Why?
|
| Open Reading Frames | 1 | 2007 | 113 | 0.060 |
Why?
|
| Female | 7 | 2024 | 48779 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 3 | 2015 | 1102 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2014 | 1690 | 0.060 |
Why?
|
| Proteolysis | 2 | 2016 | 123 | 0.060 |
Why?
|
| Kenya | 1 | 2024 | 9 | 0.050 |
Why?
|
| Enterobacteriaceae | 1 | 2024 | 22 | 0.050 |
Why?
|
| Protein Binding | 3 | 2015 | 1528 | 0.050 |
Why?
|
| Acinetobacter baumannii | 1 | 2024 | 28 | 0.050 |
Why?
|
| Health Facilities | 1 | 2024 | 40 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 329 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2024 | 150 | 0.050 |
Why?
|
| Male | 6 | 2024 | 44578 | 0.050 |
Why?
|
| Genomics | 1 | 2009 | 848 | 0.050 |
Why?
|
| Spain | 1 | 2023 | 33 | 0.050 |
Why?
|
| Binding Sites | 2 | 2016 | 1128 | 0.050 |
Why?
|
| Fluoroquinolones | 1 | 2023 | 19 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 2 | 2014 | 103 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2024 | 238 | 0.050 |
Why?
|
| Microscopy, Electron | 2 | 2012 | 433 | 0.040 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2013 | 28 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2012 | 351 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2007 | 1415 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2013 | 578 | 0.040 |
Why?
|
| Base Sequence | 2 | 2015 | 2209 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2016 | 1354 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 85 | 0.040 |
Why?
|
| Cadaver | 1 | 2019 | 199 | 0.040 |
Why?
|
| Cetuximab | 1 | 2019 | 118 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 216 | 0.040 |
Why?
|
| Species Specificity | 2 | 2011 | 683 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 259 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2019 | 271 | 0.040 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2018 | 26 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 120 | 0.030 |
Why?
|
| Carboplatin | 1 | 2019 | 322 | 0.030 |
Why?
|
| Weight Loss | 1 | 2019 | 234 | 0.030 |
Why?
|
| Models, Biological | 2 | 2018 | 1768 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2024 | 3832 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 526 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2011 | 712 | 0.030 |
Why?
|
| Cisplatin | 1 | 2019 | 568 | 0.030 |
Why?
|
| Biodiversity | 1 | 2019 | 239 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2019 | 702 | 0.030 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2016 | 12 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 484 | 0.030 |
Why?
|
| Bariatric Surgery | 1 | 2019 | 208 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2019 | 326 | 0.030 |
Why?
|
| Mutation | 3 | 2013 | 4266 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 255 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 2806 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2018 | 310 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 103 | 0.030 |
Why?
|
| Laminin | 1 | 2016 | 89 | 0.030 |
Why?
|
| Tryptophan | 1 | 2016 | 104 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2016 | 135 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2015 | 157 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 537 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 891 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 402 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 161 | 0.030 |
Why?
|
| Unilamellar Liposomes | 1 | 2015 | 5 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1177 | 0.030 |
Why?
|
| Drug Stability | 1 | 2015 | 47 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 2491 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 2015 | 24 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 476 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2015 | 125 | 0.030 |
Why?
|
| Middle Aged | 3 | 2019 | 27621 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 464 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2015 | 300 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 291 | 0.030 |
Why?
|
| Child | 1 | 2024 | 7359 | 0.020 |
Why?
|
| Phosphatidylglycerols | 1 | 2013 | 4 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2016 | 962 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 2013 | 62 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2014 | 168 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2013 | 64 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 84 | 0.020 |
Why?
|
| Bacterial Capsules | 1 | 2012 | 29 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2013 | 162 | 0.020 |
Why?
|
| Acyltransferases | 1 | 2013 | 52 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 959 | 0.020 |
Why?
|
| Crystallization | 1 | 2013 | 215 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2012 | 18 | 0.020 |
Why?
|
| Microbial Viability | 1 | 2012 | 34 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 423 | 0.020 |
Why?
|
| Coagulants | 1 | 2011 | 5 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2014 | 195 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 106 | 0.020 |
Why?
|
| Antithrombins | 1 | 2011 | 19 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2011 | 68 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2011 | 40 | 0.020 |
Why?
|
| Coagulase | 1 | 2011 | 29 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 215 | 0.020 |
Why?
|
| Lung | 1 | 2018 | 1365 | 0.020 |
Why?
|
| Longevity | 1 | 2011 | 60 | 0.020 |
Why?
|
| Conjugation, Genetic | 1 | 2011 | 18 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 438 | 0.020 |
Why?
|
| Bacillus megaterium | 1 | 2010 | 1 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2010 | 117 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2010 | 102 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 154 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2010 | 125 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 162 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1980 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 198 | 0.020 |
Why?
|
| Bacteriophages | 1 | 2010 | 42 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 304 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 27955 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2010 | 184 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 240 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 1525 | 0.020 |
Why?
|
| Computational Biology | 1 | 2013 | 578 | 0.020 |
Why?
|
| Denmark | 1 | 2009 | 19 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2009 | 18 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 273 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 4042 | 0.020 |
Why?
|
| Heart | 1 | 2011 | 522 | 0.020 |
Why?
|
| United Kingdom | 1 | 2009 | 190 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 570 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2011 | 660 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 634 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 910 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1790 | 0.020 |
Why?
|
| Anaerobiosis | 1 | 2006 | 20 | 0.020 |
Why?
|
| Aerobiosis | 1 | 2006 | 21 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2006 | 228 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2011 | 970 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 3430 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1165 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 2543 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 1866 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 1866 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 20469 | 0.010 |
Why?
|